Simulations Plus (SLP)
Builds drug-development simulation software and consulting services for biopharma clients.
$18.41
After hours0.00 (0.00%)
At close$18.41(−0.11%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 37 days
EPS estimate
$0.11
Revenue estimate
$17.6M
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Jan '25Apr '25Jul '25Dec '25Jan '26Apr '26Jul '26Oct '26
Reported$0.17$0.31$0.45$0.10$0.13$0.35$0.30Pending
Estimate$0.18$0.25$0.26$0.10$0.18$0.27$0.23$0.11
Surprise−5.6%+24.0%+73.1%0.0%−27.8%+29.6%+29.0%—
RevenueReportedEstimate
Jan '25Apr '25Jul '25Dec '25Jan '26Apr '26Jul '26Oct '26
Reported$18.9M$22.4M$20.4M$17.5M$18.4M$24.3M$21.9MPending
Estimate$18.8M$21.9M$20.9M$17.4M$18.1M$21.7M$20.9M$17.6M
Surprise+0.6%+2.3%−2.7%+0.4%+2.0%+12.2%+4.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2027 | $0.12 | — | — |
| May 2027 | $0.26 | — | — |
| Feb 2027 | $0.33 | — | — |
| Dec 2026 | $0.14 | — | — |
| Oct 2026 | $0.11 | — | — |
| Jul 2026 | $0.23 | $0.30 | +29.0% |
| Apr 2026 | $0.27 | $0.35 | +29.6% |
| Jan 2026 | $0.18 | $0.13 | −27.8% |
| Dec 2025 | $0.10 | $0.10 | 0.0% |
| Jul 2025 | |||
| Apr 2025 | |||
| Jan 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| Apr 2024 | |||
| Jan 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| Apr 2023 | |||
| Jan 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Jan 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Jan 2021 | |||
| Nov 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Jan 2020 | |||
| Nov 2019 | |||
| Jul 2019 | |||
| Apr 2019 | |||
| Jan 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Jan 2018 | |||
| Nov 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Jan 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Jan 2016 | |||
| Nov 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 2027 | $0.12 | — | — | $19.6M | — | — | — |
| May 2027 | $0.26 | — | — | $22.5M | — | — | — |
| Feb 2027 | $0.33 | — | — | $25.2M | — | — | — |
| Dec 7, 2026 | $0.14 | — | — | $19.1M | — | — | — |
| Oct 29, 2026 | $0.11 | — | — | $17.6M | — | — | — |
| Jul 9, 2026 | $0.23 | $0.30 | +29.0% | $20.9M | $21.9M | +4.7% | +0.4% |
| Apr 9, 2026 | $0.27 | $0.35 | +29.6% | $21.7M | $24.3M | +12.2% | +0.4% |
| Jan 8, 2026 | $0.18 | $0.13 | −27.8% | $18.1M | $18.4M | +2.0% | +8.6% |
| Dec 1, 2025 | $0.10 | $0.10 | 0.0% | $17.4M | $17.5M | +0.4% | +14.1% |
| Jul 14, 2025 | |||||||
| Apr 3, 2025 | |||||||
| Jan 7, 2025 | |||||||
| Oct 23, 2024 | |||||||
| Jul 2, 2024 | |||||||
| Apr 3, 2024 | |||||||
| Jan 3, 2024 | |||||||
| Oct 25, 2023 | |||||||
| Jul 6, 2023 | |||||||
| Apr 5, 2023 | |||||||
| Jan 4, 2023 | |||||||
| Oct 26, 2022 | |||||||
| Jul 6, 2022 | |||||||
| Apr 6, 2022 | |||||||
| Jan 6, 2022 | |||||||
| Oct 25, 2021 | |||||||
| Jul 12, 2021 | |||||||
| Apr 12, 2021 | |||||||
| Jan 11, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Jul 9, 2020 | |||||||
| Apr 9, 2020 | |||||||
| Jan 9, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Jul 10, 2019 | |||||||
| Apr 9, 2019 | |||||||
| Jan 9, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Jul 10, 2018 | |||||||
| Apr 9, 2018 | |||||||
| Jan 9, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Jul 10, 2017 | |||||||
| Apr 10, 2017 | |||||||
| Jan 9, 2017 | |||||||
| Nov 11, 2016 | |||||||
| Jul 14, 2016 | |||||||
| Apr 13, 2016 | |||||||
| Jan 14, 2016 | |||||||
| Nov 18, 2015 |